De Vico Antonio
Papers
1
Total Citations
34
H-Index
1
About
Antonio De Vico is a prominent urological researcher whose work centers on improving prostate cancer risk stratification and clinical decision-making. His key contributions lie in refining the use of prostate-specific antigen (PSA) density as a predictive tool for disease progression. In his highly cited 2017 study, "Prostate-Specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System," De Vico demonstrated that PSA density—a simple, readily available metric—can reliably identify patients at risk for pathological upstaging or upgrading under the contemporary Gleason grading system. This work, cited 34 times, offers clinicians a practical, cost-effective strategy to avoid overtreatment and better select candidates for active surveillance. By validating a familiar biomarker in a new context, De Vico has helped bridge the gap between routine clinical data and precision oncology. His research empowers urologists with evidence-based tools to personalize treatment, ultimately improving outcomes for men with prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1